We are delighted to introduce the first edition of the Glen Research Report but first, some words about our company may be appropriate. Glen Research Corporation was founded in January of this year to provide products and services to researchers in the field of biotechnology. With a background and experience in DNA synthesis, it was natural for us to present an initial product line of reagents for DNA synthesis. As the company grows, we are committed to introduce novel products for DNA manipulation, as well as new products for other areas of biotechnology research.
Already, Glen Research offers one of the most complete lines of reagents for DNA synthesis, both for routine use and for research applications. Our commitment to research applications will, of course, continue and some novel products will be discussed in this and future Research Reports.
In this first edition of the Glen Research Report, we will highlight some recent developments in chemical modification of DNA to produce oligonucleotides which may prove to have utility in AIDS and other anti-viral research.
